Biohorizons
Payments companies reported to CMS as associated with Biohorizons. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biohorizons, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biohorizons
These are the largest totals companies reported as associated with Biohorizons. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Pikos | Palm Harbor, FL | Oral and Maxillofacial Surgery | $3,973,695.90 |
| Edward Allen | Dallas, TX | Periodontics | $1,668,315.40 |
| Andrew Ferrier | Lafayette, CA | Prosthodontics | $1,194,385.35 |
| Carl Medgaus | Monroeville, PA | General Practice (Dentist) | $876,677.70 |
| Bart Silverman | New City, NY | Oral and Maxillofacial Surgery | $789,906.20 |
| Rickie Ferguson | Pembroke Pines, FL | General Practice (Dentist) | $712,336.45 |
| Arshiya Sharafi | San Diego, CA | Oral and Maxillofacial Surgery | $652,575.15 |
| Hom-Lay Wang | Ann Arbor, MI | Dentist | $562,810.40 |
| Daniel Cullum | Coeur D Alene, ID | Oral and Maxillofacial Surgery | $318,942.35 |
| Robert Stanley | Cary, NC | Dentist | $286,427.30 |
Prescribed Biohorizons?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.